CTRI/2023/10/058696
Not yet recruiting
未知
A Study on Association of Interleukin Gene (IL) Expression and Progression Free Survival in Stage IV Non-Small Cell Lung Cancer in a Tertiary Care Hospital - NI
Institute of Medical sciences and SUM Hospital SOA University0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
- Sponsor
- Institute of Medical sciences and SUM Hospital SOA University
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients age \= 18 yrs.
- •2\. Histopathology/cytology\-proven NSCLC
- •3\. Stage IV disease measured by CECT/PET CT
- •4\. Adequate organ function.
Exclusion Criteria
- •1\. Consent refusal
- •2\. Patients already on chemotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Relationship of herpes virus with interleukin in gum diseasesCTRI/2018/07/015141Dr Shivaprasad BM
Not yet recruiting
Not Applicable
Relationship between levels of Interleukin-1a in gum fluid and the development of root resorption after dental injury.CTRI/2024/07/070145nithiyalakshmi kanagaraj
Recruiting
Phase 3
Relationship between IL6 and fatigue induced by radiotherapy and chemotherapy in patients treated with Melatonin drugBreast CanceCancer Related FatigueMelatoninInterleukin 6.Malignant neoplasm of breastIRCT20180426039421N2Hamedan University of Medical Sciences64
Not yet recruiting
Not Applicable
The study of relationship between Immune-related adverse events with immune checkpoint blockade and microbiota changegastric cancer, non-small-cell lung cancerJPRN-UMIN000030437Osaka medical college30
Active, not recruiting
Phase 1
Interleukin-1 (IL-1) and Interferon gamma (IFNg) inhibition during COVID 19 inflammation: Randomized, controlled study assessing efficacy and safety of Anakinra and RuxolitinibCovid-19 diseaseTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001963-10-FRCentre Hospitalier Intercommunal de Toulon La Seyne-sur-mer54